Table 5.
Univariate analysis for synchronous metastatic disease
| Possible explicative variables | OR | p-value | 95% CI |
|---|---|---|---|
| Sex | 2.312 | 0.305 | 0.466–11.470 |
| Age | 0.997 | 0.938 | 0.936–1.062 |
| Mucinous | 0.952 | 0.953 | 0.188–4.823 |
| mT4 | 0.564 | 0.485 | 0.113–2.813 |
| mN2 | 1.413 | 0.608 | 0.376–5.312 |
| MRF+ | 1.153 | 0.833 | 0.305–4.352 |
| mEMVI | 9.931 | 0.005 | 1.988–49.600 |
| ADCmin (10−3) | 0.634 | 0.070 | 0.003–1.251 |
| DWI volume | 0.990 | 0.509 | 0.961–1.019 |
| T2w volume | 0.994 | 0.587 | 0.972–1.015 |
| MTV | 0.997 | 0.708 | 0.983–1.011 |
| TLG | 0.999 | 0.851 | 0.999–1.000 |
| SUVmax | 1.001 | 0.949 | 0.957–1.048 |
ADCmin, minimum apparent diffusion coefficient; CI, confidence interval; DWI, diffusion-weighted imaging; mEMVI, extramural venous invasion; MRF, mesorectal fascia; MTV, metabolic tumour volume; OR, odds ratio; SUVmax, maximum standardized uptake value; T2w, T2 weighted; TLG, total lesion glycolysis.